Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
NITAG documentation
Older adults
Recommendation
Clear all
Type of publications
NITAG documentation
(10)
Topics
Recommendation
(10)
Regions
Americas
(5)
Europe
(4)
Western Pacific
(1)
Countries
Australia
(1)
Belgium
(1)
Canada
(2)
Chile
(2)
Ireland
(1)
Netherlands
(1)
United Kingdom
(1)
United States of America
(1)
Diseases
COVID-19
(4)
Pneumococcal disease
(2)
RSV (Respiratory syncytial virus)
(4)
Publication date
2024
(1)
2023
(6)
2021
(1)
2020
(2)
Target population
Older adults
(10)
Adolescents
(4)
Adults
(6)
All age groups
(1)
Children
(21)
Healthcare workers
(3)
Migrants
(1)
Newborn
(8)
Pregnant women
(7)
Risk group
(5)
Available to download in languages
English (EN)
(8)
Spanish (ES)
(2)
French (FR)
(1)
10 results found
2024
∙
NACI
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
2023
∙
CAVEI
CAVEI RECOMMENDATION ON VACCINATION INCORPORATION AGAINST RESPIRATORY SYNCYCIAL VIRUS IN OLDER ADULTS AND PREGNANT WOMEN IN THE NATIONAL IMMUNIZATION PROGRAM
2023
∙
NIAC
NIAC RECOMMENDATIONS FOR PASSIVE IMMUNISATION AND VACCINATION AGAINST RESPIRATORY SYNCYTIAL VIRUS IN INFANTS, CHILDREN AND OLDER ADULTS
2023
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against RSV (adults) in Belgium
2023
∙
ACIP
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices
2023
Pneumococcal vaccination of the elderly in the netherlands
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
2020
∙
CAVEI
CAVEI recommendation to prioritize vaccination against SARS-COV-2 in people over 65 years in the context of limited supply of vaccines
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register